Drugs / Levidopa
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT07709741 Comparator | Apr → Jun 2027 expected | — | University of Minnesota | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levidopa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07709741 ↗ |
| Route | Oral | “The assembly is placed in the oral/buccal cavity (between cheek and gum of lower jaw) and delivers continuous release of CD and LD for both transmucosal and gastrointestinal absorption.” NCT07709741 ↗ |